HERON THERAPEUTICS, INC. /DE/ Investment Income, Interest
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Investment Income, Interest of $1.95 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-02-26
- HERON THERAPEUTICS, INC. /DE/ investment income, interest for the quarter ending 2016-12-31 was $119.00K, a 83.08% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ investment income, interest for the quarter ending 2016-09-30 was $111.00K, a 81.97% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ investment income, interest for the quarter ending 2016-06-30 was $97.00K, a 273.08% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ investment income, interest for the quarter ending 2016-03-31 was $118.00K, a 436.36% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ investment income, interest for fiscal 2025 was $1.95M, a 45.13% decline from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ investment income, interest for fiscal 2024 was $3.55M, a 5.53% increase from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ investment income, interest for fiscal 2023 was $3.36M, a 105.37% increase from fiscal 2022.
- HERON THERAPEUTICS, INC. /DE/ investment income, interest for fiscal 2022 was $1.64M, a 278.29% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.95M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $3.55M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $3.36M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $1.64M 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $433.00K 10-K · filed 2023-03-29 | |||
| 2020-12-31 | $3.63M 10-K · filed 2022-02-28 | |||
| 2019-12-31 | $7.26M 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $5.96M 10-K · filed 2021-02-24 | |||
| 2017-12-31 | $1.05M 10-K · filed 2020-03-02 | |||
| 2016-12-31 | $119.00K 10-K · filed 2017-02-23 | $230.00K derived: sum of 2 quarters · filed 2017-02-23 | $327.00K derived: sum of 3 quarters · filed 2017-02-23 | $445.00K 10-K · filed 2019-02-22 |
| 2016-09-30 | $111.00K 10-K · filed 2017-02-23 | $208.00K derived: sum of 2 quarters · filed 2017-02-23 | $326.00K derived: sum of 3 quarters · filed 2017-02-23 | $391.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2016-06-30 | $97.00K 10-K · filed 2017-02-23 | $215.00K derived: sum of 2 quarters · filed 2017-02-23 | $280.00K derived: sum of 3 quarters · filed 2017-02-23 | $341.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2016-03-31 | $118.00K 10-K · filed 2017-02-23 | $183.00K derived: sum of 2 quarters · filed 2017-02-23 | $244.00K derived: sum of 3 quarters · filed 2017-02-23 | $270.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-12-31 | $65.00K 10-K · filed 2017-02-23 | $126.00K derived: sum of 2 quarters · filed 2017-02-23 | $152.00K derived: sum of 3 quarters · filed 2017-02-23 | $174.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | $61.00K 10-K · filed 2017-02-23 | $87.00K derived: sum of 2 quarters · filed 2017-02-23 | $109.00K derived: sum of 3 quarters · filed 2017-02-23 | $112.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $26.00K 10-K · filed 2017-02-23 | $48.00K derived: sum of 2 quarters · filed 2017-02-23 | $51.00K derived: sum of 3 quarters · filed 2017-02-23 | |
| 2015-03-31 | $22.00K 10-K · filed 2017-02-23 | $25.00K derived: sum of 2 quarters · filed 2017-02-23 | ||
| 2014-12-31 | $3.00K 10-K · filed 2016-02-19 | |||
| 2013-06-30 | $1.00K 10-K · filed 2015-03-13 | |||
| 2012-03-31 | $1.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |